Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance

Multidrug resistance in cancer: role of ATP–dependent transporters

Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536

Targeting multidrug resistance in cancer

Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Vogelzang, N. J., Rusthoven, J. J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., Gatzemeier, U., Boyer, M., Emri, S., Manegold, C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.136 · Cited by 3,060

Major Facilitator Superfamily

Pao, S. S., Paulsen, I. T., & Saier, M. H. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.1-34.1998 · Cited by 2,297

Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)

Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

HEIDELBERGER, C., CHAUDHURI, N. K., DANNEBERG, P., MOOREN, D., GRIESBACH, L., DUSCHINSKY, R., SCHNITZER, R. J., PLEVEN, E., & SCHEINER, J. (1957) · Nature · doi:10.1038/179663a0 · Cited by 1,603

Mammalian ABC Transporters in Health and Disease

Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

van Dam, G. M., Themelis, G., Crane, L. M. A., Harlaar, N. J., Pleijhuis, R. G., Kelder, W., Sarantopoulos, A., de Jong, J. S., Arts, H. J. G., van der Zee, A. G. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2472 · Cited by 1,545

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197

Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells.

Alt, F. W., Kellems, R. E., Bertino, J. R., & Schimke, R. T. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34875-5 · Cited by 941

Folate-mediated delivery of macromolecular anticancer therapeutic agents

Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications

Ross, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s · Cited by 891

Identification of an Intestinal Folate Transporter and the Molecular Basis for Hereditary Folate Malabsorption

Qiu, A., Jansen, M., Sakaris, A., Min, S. H., Chattopadhyay, S., Tsai, E., Sandoval, C., Zhao, R., Akabas, M. H., & Goldman, I. D. (2006) · Cell · doi:10.1016/j.cell.2006.09.041 · Cited by 847

Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins

Deeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761

Identification of an Intestinal Heme Transporter

Shayeghi, M., Latunde-Dada, G. O., Oakhill, J. S., Laftah, A. H., Takeuchi, K., Halliday, N., Khan, Y., Warley, A., McCann, F. E., Hider, R. C., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.025 · Cited by 755

Compartmentalization of Mammalian Folate-Mediated One-Carbon Metabolism

Tibbetts, A. S., & Appling, D. R. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104810 · Cited by 692 · cited 2×

Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy

Elnakat, H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.001 · Cited by 649

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

O'Connor, O. A., Pro, B., Pinter-Brown, L., Bartlett, N., Popplewell, L., Coiffier, B., Jo Lechowicz, M., Savage, K. J., Shustov, A. R., Gisselbrecht, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.9024 · Cited by 647

Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics

Hilgenbrink, A. R., & Low, P. S. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20457 · Cited by 625

Folate-targeted therapeutic and imaging agents for cancer

Low, P. S., & Kularatne, S. A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.022 · Cited by 585

LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.

Shih, C., Chen, V. J., Gossett, L. S., Gates, S. B., MacKellar, W. C., Habeck, L. L., Shackelford, K. A., Mendelsohn, L. G., Soose, D. J., Patel, V. F., et al. (1997) · PubMed · Cited by 560

Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5'-terminal Regulatory Region of the Human Gene for Thymidylate Synthase.

Horie, N., Aiba, H., Oguro, K., Hojo, H., & Takeishi, K. (1995) · Cell Structure and Function · doi:10.1247/csf.20.191 · Cited by 547

The role of folate receptor α in cancer development, progression and treatment: Cause, consequence or innocent bystander?

Kelemen, L. E. (2006) · International Journal of Cancer · doi:10.1002/ijc.21712 · Cited by 509

The MRP4/ABCC4 Gene Encodes a Novel Apical Organic Anion Transporter in Human Kidney Proximal Tubules: Putative Efflux Pump for Urinary cAMP and cGMP

van Aubel, R. A. M. H., Smeets, P. H. E., Peters, J. G. P., Bindels, R. J. M., & Russel, F. G. M. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133595 · Cited by 501

Folate-targeted therapies for cancer

Xia, W., & Low, P. S. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100509v · Cited by 448

Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.

Hooijberg, J. H., Broxterman, H. J., Kool, M., Assaraf, Y. G., Peters, G. J., Noordhuis, P., Scheper, R. J., Borst, P., Pinedo, H. M., & Jansen, G. (1999) · PubMed · Cited by 442

The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway.

Rothberg, K. G., Ying, Y. S., Kolhouse, J. F., Kamen, B. A., & Anderson, R. G. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.3.637 · Cited by 441

Isolation and expression of an altered mouse dihydrofolate reductase cDNA.

Simonsen, C. C., & Levinson, A. D. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2495 · Cited by 417

Chapter 1 Folate‐Mediated One‐Carbon Metabolism

Fox, J. T., & Stover, P. J. (2008) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)00401-9 · Cited by 402

Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues

Zhao, R., Matherly, L. H., & Goldman, I. D. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000969 · Cited by 392

Membrane Transport of Folates

Matherly, L. H., & Goldman, I. D. (2003) · Vitamins & Hormones · doi:10.1016/s0083-6729(03)01012-4 · Cited by 386

Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.

Chu, E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C., Zinn, S., & Allegra, C. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8977 · Cited by 382

Amplified dihydrofolate reductase genes in unstably methotrexate-resistant cells are associated with double minute chromosomes.

Kaufman, R. J., Brown, P. C., & Schimke, R. T. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.11.5669 · Cited by 376

Carrier-mediated Transport of the Folic Acid Analogue, Methotrexate, in the L1210 Leukemia Cell

Goldman, I. D., Lichtenstein, N. S., & Oliverio, V. T. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91984-8 · Cited by 372

Amplified dihydrofolate reductase genes are localized to a homogeneously staining region of a single chromosome in a methotrexate-resistant Chinese hamster ovary cell line.

Nunberg, J. H., Kaufman, R. J., Schimke, R. T., Urlaub, G., & Chasin, L. A. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5553 · Cited by 364

ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.

Jackman, A. L., Taylor, G. A., Gibson, W., Kimbell, R., Brown, M., Calvert, H., Judson, I. R., & Lr, H. (1991) · PubMed · Cited by 357

The folate receptor: What does it promise in tissue-targeted therapeutics?

Salazar, M. D., & Ratnam, M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9048-0 · Cited by 350

Molecular basis of antifolate resistance

Assaraf, Y. G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9049-z · Cited by 338

Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates.

Allegra, C. J., Chabner, B. A., Drake, J. C., Lutz, R., Rodbard, D., & Jolivet, J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39298-0 · Cited by 335

Interactions of the Human Multidrug Resistance Proteins MRP1 and MRP2 with Organic Anions

Bakos, É., Evers, R., Sinkó, E., Váradi, A., Borst, P., & Sarkadi, B. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26477-4 · Cited by 322

Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system.

Chen, Z., Lee, K., WALTHER, S. E., Raftogianis, R. B., Kuwano, M., Zeng, H., & Kruh, G. D. (2002) · PubMed · Cited by 316

Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis

Paulos, C. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.012 · Cited by 290

THE CHARACTERISTICS OF THE MEMBRANE TRANSPORT OF AMETHOPTERIN AND THE NATURALLY OCCURRING FOLATES

Goldman, I. D. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb31167.x · Cited by 288

Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles.

Kamen, B. A., Wang, M. T., Streckfuss, A. J., Peryea, X., & Anderson, R. G. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68284-5 · Cited by 287

Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications

Chattopadhyay, S., Moran, R. G., & Goldman, I. D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0343 · Cited by 281

Phase III Randomized Controlled Trial Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma Treated With Nolatrexed or Doxorubicin

Gish, R. G., Porta, C., Lazar, L., Ruff, P., Feld, R., Croitoru, A., Feun, L., Jeziorski, K., Leighton, J., Knox, J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.4046 · Cited by 279

Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness

Labay, V., Raz, T., Baron, D., Mandel, H., Williams, H., Barrett, T., Szargel, R., McDonald, L., Shalata, A., Nosaka, K., et al. (1999) · Nature Genetics · doi:10.1038/10372 · Cited by 275

Folic acid metabolism in health and disease

Price, J. (1991) · Trends in Food Science & Technology · doi:10.1016/0924-2244(91)90712-r · Cited by 269

Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene.

Ulrich, C. M., Bigler, J., Velicer, C. M., Greene, E. A., Farin, F. M., & Potter, J. D. (2000) · PubMed · Cited by 259

Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport.

Zeng, H., Chen, Z., Belinsky, M. G., Rea, P. A., & Kruh, G. D. (2001) · PubMed · Cited by 255

A dideazatetrahydrofolate analog lacking a chiral center at C-6: N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5yl)ethyl[benzoyl]-L-glutamic acid is an inhibitor of thymidylate synthase

Taylor, E. C., Kuhnt, D., Shih, C., Rinzel, S. M., Grindey, G. B., Barredo, J., Jannatipour, M., & Moran, R. G. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00101a023 · Cited by 254

Resistance to antifolates

Zhao, R., & Goldman, I. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206946 · Cited by 253

Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase

Banerjee, D., Mayer-Kuckuk, P., Capiaux, G., Budak-Alpdogan, T., Gorlick, R., & Bertino, J. R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00079-0 · Cited by 242

A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells.

Dixon, K. H., Lanpher, B. C., Chiu, J., Kelley, K., & Cowan, K. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42301-5 · Cited by 240

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

Naumann, R. W., Coleman, R. L., Burger, R. A., Sausville, E. A., Kutarska, E., Ghamande, S. A., Gabrail, N. Y., DePasquale, S. E., Nowara, E., Gilbert, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.7685 · Cited by 238

Transport of amphipathic anions by human multidrug resistance protein 3.

Zeng, H., Liu, G., Rea, P. A., & Kruh, G. D. (2000) · PubMed · Cited by 235

The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis

Assaraf, Y. G. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.09.001 · Cited by 235

A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis

Beardsley, G. P., Moroson, B. A., Taylor, E. C., & Moran, R. G. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31261-9 · Cited by 231

Identification of a novel folate receptor, a truncated receptor, and receptor type .beta. in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity

Shen, F., Ross, J. F., Wang, X., & Ratnam, M. (1994) · Biochemistry · doi:10.1021/bi00171a021 · Cited by 231

Folate receptor type ? is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia

Ross, J. F., Wang, H., Behm, F. G., Mathew, P., Wu, M., Booth, R., & Ratnam, M. (1999) · Cancer · Cited by 225

The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter

Fleming, J. C., Tartaglini, E., Steinkamp, M. P., Schorderet, D. F., Cohen, N., & Neufeld, E. J. (1999) · Nature Genetics · doi:10.1038/10379 · Cited by 224

ABCG2: structure, function and role in drug response

Polgar, O., Robey, R. W., & Bates, S. E. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.1.1 · Cited by 224

Analysis of the MRP4 Drug Resistance Profile in Transfected NIH3T3 Cells

Lee, K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1934 · Cited by 222

Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.

Volk, E. L., & Schneider, E. (2003) · PubMed · Cited by 215

Enzymatic synthesis of folylpolyglutamates. Characterization of the reaction and its products.

McGuire, J. J., Hsieh, P., Coward, J. K., & Bertino, J. R. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70697-8 · Cited by 213

Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5′-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide

Baggott, J. E., Vaughn, W. H., & Hudson, B. B. (1986) · Biochemical Journal · doi:10.1042/bj2360193 · Cited by 205

Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome

Diaz, G. A., Banikazemi, M., Oishi, K., Desnick, R. J., & Gelb, B. D. (1999) · Nature Genetics · doi:10.1038/10385 · Cited by 205

Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.

Westerhof, G. R., Schornagel, J. H., Kathmann, I., Jackman, A. L., Rosowsky, A., Forsch, R. A., Hynes, J. B., Boyle, F. T., Peters, G. J., & Pinedo, H. M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10494-x · Cited by 204

Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA

Ratnam, M., Marquardt, H., Duhring, J. L., & Freisheim, J. H. (1989) · Biochemistry · doi:10.1021/bi00446a042 · Cited by 200

Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells.

Moscow, J. A., Gong, M., He, R., Sgagias, M. K., Dixon, K. H., Anzick, S. L., Meltzer, P. S., & Cowan, K. H. (1995) · PubMed · Cited by 199

Cloning of the Human Thiamine Transporter, a Member of the Folate Transporter Family

Dutta, B., Huang, W., Molero, M., Kekuda, R., Leibach, F. H., Devoe, L. D., Ganapathy, V., & Prasad, P. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31925 · Cited by 196

Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.

Sirotnak, F. M., Moccio, D. M., Kelleher, L. E., et al. (1981) · PubMed · Cited by 189

Isolation of Human cDNAs That Restore Methotrexate Sensitivity and Reduced Folate Carrier Activity in Methotrexate Transport-defective Chinese Hamster Ovary Cells

Wong, S. C., Proefke, S. A., Bhushan, A., & Matherly, L. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17468 · Cited by 187

Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refractory Lymphoma Reveals Marked Activity in T-Cell Malignancies

O'Connor, O. A., Horwitz, S., Hamlin, P., Portlock, C., Moskowitz, C. H., Sarasohn, D., Neylon, E., Mastrella, J., Hamelers, R., MacGregor-Cortelli, B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8470 · Cited by 187

Crystal structure of unliganded Escherichia coli dihydrofolate reductase. Ligand-induced conformational changes and cooperativity in binding

Bystroff, C., & Kraut, J. (1991) · Biochemistry · doi:10.1021/bi00222a028 · Cited by 186

From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates

Walling, J. (2006) · Investigational New Drugs · doi:10.1007/s10637-005-4541-1 · Cited by 182

Identification of an RNA binding site for human thymidylate synthase.

Chu, E., Voeller, D., Koeller, D. M., Drake, J. C., Takimoto, C. H., Maley, G. F., Maley, F., & Allegra, C. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.517 · Cited by 178

Thymidylate synthase inhibitors as anticancer agents: from bench to bedside

Chu, E., Callender, M. A., Farrell, M. P., & Schmitz, J. C. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0625-9 · Cited by 174

BindingDB Entry 50042069: Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats.

BindingDB (2013) · PubMed · doi:10.7270/q2571d9z · Cited by 172

Polygammaglutamyl metabolites of methotrexate

Baugh, C. M., Krumdieck, C. L., & Nair, M. G. (1973) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(73)90949-2 · Cited by 171

Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer

Takezawa, K., Okamoto, I., Okamoto, W., Takeda, M., Sakai, K., Tsukioka, S., Kuwata, K., Yamaguchi, H., Nishio, K., & Nakagawa, K. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.129 · Cited by 170

Folate Receptor Type .gamma. Is Primarily a Secretory Protein Due to Lack of an Efficient Signal for Glycosylphosphatidylinositol Modification: Protein Characterization and Cell Type Specificity

Shen, F., Wu, M., Ross, J. F., Miller, D., & Ratnam, M. (1995) · Biochemistry · doi:10.1021/bi00016a042 · Cited by 168

Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates

Xin, W., Feng, S., Freisheim, J. H., Gentry, L. E., & Ratnam, M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90089-2 · Cited by 167

Molecular Cloning of the Human Placental Folate Transporter

Prasad, P. D., Ramamoorthy, S., Leibach, F. H., & Ganapathy, V. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1096 · Cited by 163

Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based Chemotherapy

Righi, L., Papotti, M. G., Ceppi, P., Billè, A., Bacillo, E., Molinaro, L., Ruffini, E., Scagliotti, G. V., & Selvaggi, G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9275 · Cited by 160

Folate-based thymidylate synthase inhibitors as anticancer drugs

Jackman, A. L., & Calvert, A. H. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059353 · Cited by 160

SLC19A3 encodes a second thiamine transporter ThTr2

Rajgopal, A., Edmondnson, A., Goldman, I. D., & Zhao, R. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00073-4 · Cited by 158

The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption

Zhao, R., Min, S. H., Qiu, A., Sakaris, A., Goldberg, G. L., Sandoval, C., Malatack, J. J., Rosenblatt, D. S., & Goldman, I. D. (2007) · Blood · doi:10.1182/blood-2007-02-077099 · Cited by 156

A Role for the Proton-coupled Folate Transporter (PCFT-SLC46A1) in Folate Receptor-mediated Endocytosis

Zhao, R., Min, S. H., Wang, Y., Puchulu‐Campanella, E., Low, P. S., & Goldman, I. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807665200 · Cited by 155

Management strategies for recurrent platinum-resistant ovarian cancer

Naumann, R. W., & Coleman, R. L. (2011) · Drugs · doi:10.2165/11591720-000000000-00000 · Cited by 152

Interaction of folylpolyglutamates with enzymes in one-carbon metabolism

Schirch, V., & Strong, W. B. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90120-3 · Cited by 152

Mechanisms of methotrexate resistance in osteosarcoma.

Guo, W., Healey, J. H., Meyers, P. A., Ladanyi, M., Huvos, A. G., Bertino, J. R., & Gorlick, R. G. (1999) · PubMed · Cited by 152

Therapeutics by Cytotoxic Metabolite Accumulation: Pemetrexed Causes ZMP Accumulation, AMPK Activation, and Mammalian Target of Rapamycin Inhibition

Racanelli, A. C., Rothbart, S. B., Heyer, C. L., & Moran, R. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4979 · Cited by 149

Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression

Sigmond, J., Backus, H. H. J., Wouters, D., Temmink, O. H., Jansen, G., & Peters, G. J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00287-9 · Cited by 147

Methylation-dependent Silencing of the Reduced Folate Carrier Gene in Inherently Methotrexate-resistant Human Breast Cancer Cells

Worm, J., Kirkin, A. F., Dzhandzhugazyan, K. N., & Guldberg, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103181200 · Cited by 146

Amplification of the human dihydrofolate reductase gene via double minutes is initiated by chromosome breaks

Singer, M. J., Mesner, L. D., Friedman, C. L., Trask, B. J., & Hamlin, J. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130194897 · Cited by 144

Methotrexate-resistant Variants of Human Dihydrofolate Reductase with Substitutions of Leucine 22

Lewis, W. S., Cody, V., Galitsky, N., Luft, J. R., Pangborn, W. A., Chunduru, S. K., Spencer, H. T., Appleman, J. R., & Blakley, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5057 · Cited by 144

The Human Multidrug Resistance Protein MRP5 Transports Folates and Can Mediate Cellular Resistance against Antifolates

Wielinga, P. R., Hooijberg, J. H., Gunnarsdottir, S., Kathmann, I., Reid, G., Zelcer, N., van der Born, K., de Haas, M., van der Heijden, I., Kaspers, G. J. L., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2810 · Cited by 139

Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro

Chu, E., Takimoto, C. H. M., Voeller, D. M., Grem, J. L., & Allegra, C. J. (1993) · Biochemistry · doi:10.1021/bi00069a009 · Cited by 138

Unstable amplification of an altered dihydrofolate reductase gene associated with double-minute chromosomes

Haber, D. A., & SCHIMKE, R. T. (1981) · Cell · doi:10.1016/0092-8674(81)90204-x · Cited by 136

The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter

Whetstine, J. R., Flatley, R. M., & Matherly, L. H. (2002) · Biochemical Journal · doi:10.1042/bj20020512 · Cited by 136

FDA Drug Approval Summaries: Pemetrexed (Alimta®)

Hazarika, M., White, R. M., Johnson, J. R., & Pazdur, R. (2004) · The Oncologist · doi:10.1634/theoncologist.9-5-482 · Cited by 132

Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity.

Rhee, M. S., Wang, Y., Nair, M. G., et al. (1993) · PubMed · Cited by 132

Retrovirally Mediated Complementation of the glyBPhenotype

Titus, S. A., & Moran, R. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005163200 · Cited by 130

The Proton-Coupled Folate Transporter: Impact on Pemetrexed Transport and on Antifolates Activities Compared with the Reduced Folate Carrier

Zhao, R., Qiu, A., Tsai, E., Jansen, M., Akabas, M. H., & Goldman, I. D. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045443 · Cited by 129

Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase.

Appleman, J. R., Prendergast, N. J., Delcamp, T. J., et al. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81516-8 · Cited by 128

The role of thymidylate synthase as an RNA binding protein

Chu, E., & Allegra, C. J. (1996) · BioEssays · doi:10.1002/bies.950180306 · Cited by 126

Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction

Qiu, A., Min, S. H., Jansen, M., Malhotra, U., Tsai, E., Cabelof, D. C., Matherly, L. H., Zhao, R., Akabas, M. H., & Goldman, I. D. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00202.2007 · Cited by 126

Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux.

Volk, E. L., Rohde, K., Rhee, M., McGuire, J. J., Doyle, L. A., Ross, D. D., & Schneider, E. (2000) · PubMed · Cited by 125

Characterization of a Mutation in the Reduced Folate Carrier in a Transport Defective L1210 Murine Leukemia Cell Line

Brigle, K. E., Spinella, M. J., Sierra, E. E., & Goldman, I. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.22974 · Cited by 125

Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells

Zhao, R., Gao, F., & Goldman, I. D. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00547.2001 · Cited by 124

Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake.

Williams, F. M. K., Murray, R. C., Underhill, T. M., & Flintoff, W. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37534-8 · Cited by 119

Folate metabolism in mammalian cells in culture. I Partial characterization of the folate derivatives present in L1210 mouse leukemia cells.

Moran, R. G., Werkheiser, W. C., & Zakrzewski, S. F. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33382-3 · Cited by 115

Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers.

Whetstine, J. R., Gifford, A. J., Witt, T. L., Liu, X. Y., Flatley, R. M., Norris, M. D., Haber, M., Taub, J. W., Ravindranath, Y., & Matherly, L. H. (2001) · PubMed · Cited by 114

Loss of folylpoly‐γ‐glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation‐dependent novel antifolates in multiple human leukemia sublines

Liani, E., Rothem, L., Bunni, M. A., Smith, C. A., Jansen, G., & Assaraf, Y. G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10829 · Cited by 113

Studies with a mathematical model of folate metabolism

Jackson, R., & Harrap, K. R. (1973) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(73)90579-1 · Cited by 110

Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexate

Flintoff, W. F., & Essani, K. (1980) · Biochemistry · doi:10.1021/bi00559a027 · Cited by 105

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin

Zucali, P. A., Giovannetti, E., Destro, A., Mencoboni, M., Ceresoli, G. L., Gianoncelli, L., Lorenzi, E., Vincenzo, F. D., Simonelli, M., Perrino, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2873 · Cited by 103

Two different species of dihydrofolate reductase in mammalian cells differentially resistant to amethopterin and methasquin.

Albrecht, A., Biedler, J. L., & Hutchison, D. J. (1972) · PubMed · Cited by 102

Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines

Jackman, A. L., Kèlland, L. R., Kimbell, R., Brown, M., Gibson, W. H., Aherne, G. W., Hardcastle, A., & Boyle, F. T. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.178 · Cited by 102

BGC 945, a Novel Tumor-Selective Thymidylate Synthase Inhibitor Targeted to α-Folate Receptor–Overexpressing Tumors

Gibbs, D. D., Theti, D. S., Wood, N., Green, M., Raynaud, F. I., Valenti, M. R., Forster, M. D., Mitchell, F., Bavetsias, V., Henderson, E. A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2034 · Cited by 101

Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.

Jansen, G., Westerhof, G. R., Jarmuszewski, M. J., Kathmann, I., Rijksen, G., & Schornagel, J. H. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44748-x · Cited by 98

Antifolates targeted specifically to the folate receptor

Jackman, A. L. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.003 · Cited by 97

Regulation of folate and one-carbon metabolism in mammalian cells. III. Role of mitochondrial folylpoly-gamma-glutamate synthetase.

Lin, B., Huang, R., & Shane, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80594-8 · Cited by 96

Modulation of the folate receptor alpha gene by the estrogen receptor: mechanism and implications in tumor targeting.

Kelley, K. M. M., Rowan, B. G., & Ratnam, M. (2003) · PubMed · Cited by 96

Folate Targeting Enables Durable and Specific Antitumor Responses from a Therapeutically Null Tubulysin B Analogue

Leamon, C. P., Reddy, J. A., Vetzel, M., Dorton, R., Westrick, E. M., Parker, N. L., Wang, Y., & Vlahov, I. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2341 · Cited by 96

Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426

Adjei, A. A., Mandrekar, S. J., Dy, G. K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6406 · Cited by 96

A functional-phylogenetic system for the classification of transport proteins

Saier, M. H. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1999)75:32+<84::aid-jcb11>3.0.co;2-m · Cited by 96

Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations

DeVos, L., Chanson, A., Liu, Z., Ciappio, E. D., Parnell, L. D., Mason, J. B., Tucker, K. L., & Crott, J. W. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.4.1149 · Cited by 96

Biochemical pharmacology of the lipophilic antifolate, trimetrexate

Jackson, R., Fry, D. W., Boritzki, T. J., et al. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90014-1 · Cited by 95

A Prominent Low-pH Methotrexate Transport Activity in Human Solid Tumors

Zhao, R., Gao, F., Hanscom, M., & Goldman, I. D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1066-03 · Cited by 95

Biological activity of the multitargeted antifolate, MTA (LY231514), in human cell lines with different resistance mechanisms to antifolate drugs.

Schultz, R. M., Vj, C., Bewley, J. R., Roberts, E. F., Shih, C., & Dempsey, J. A. (1999) · PubMed · Cited by 93

AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies

Webber, S. E., Bartlett, C. A., Boritzki, T. J., Hilliard, J. A., Howland, E. F., Johnston, A. L., Kosa, M. B., Margosiak, S. A., Morse, C. A., & Shetty, B. V. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050422 · Cited by 91

A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in mice

Sirotnak, F. M., DeGraw, J. I., Colwell, W. T., & Piper, J. R. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050823 · Cited by 91

N-linked glycosylation and its impact on the electrophoretic mobility and function of the human proton-coupled folate transporter (HsPCFT)

Unal, E. S., Zhao, R., Qiu, A., & Goldman, I. D. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.03.009 · Cited by 91

Design and Synthesis of Cyclopenta[g]quinazoline-Based Antifolates as Inhibitors of Thymidylate Synthase and Potential Antitumor Agents,

Bavetsias, V., Marriott, J. H., Melin, C., Kimbell, R., Matusiak, Z. S., Boyle, F. T., & Jackman, A. L. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm991119p · Cited by 91

Impact of the Reduced Folate Carrier on the Accumulation of Active Thiamin Metabolites in Murine Leukemia Cells

Zhao, R., Gao, F., Wang, Y., Diaz, G. A., Gelb, B. D., & Goldman, I. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007919200 · Cited by 90

Ultrastructural features of minute chromosomes in a methotrexate-resistant mouse 3T3 cell line

Hamkalo, B. A., Farnham, P., Johnston, R. N., & SCHIMKE, R. T. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.4.1126 · Cited by 90

The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.

Zhao, R. C., Babani, S., Gao, F., Liu, L., & Goldman, I. D. (2000) · PubMed · Cited by 89

THE “INDUCTION” OF DIHYDROFOLIC REDUCTASE ACTIVITY IN LEUKOCYTES AND ERYTHROCYTES OF PATIENTS TREATED WITH AMETHOPTERIN*

Bertino, J. R., Donohue, D. M., Simmons, B. S., Gabrio, B. W., Silber, R., & Huennekens, F. M. (1963) · Journal of Clinical Investigation · doi:10.1172/jci104735 · Cited by 89

Differentiation-independent retinoid induction of folate receptor type β, a potential tumor target in myeloid leukemia

Wang, H., Zheng, X., Behm, F. G., & Ratnam, M. (2000) · Blood · doi:10.1182/blood.v96.10.3529 · Cited by 88

Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas

Ferreri, A. J. M., Dell’Oro, S., Capello, D., Ponzoni, M., Iuzzolino, P., Rossi, D., Pasini, F., Ambrosetti, A., Orvieto, E., Ferrarese, F., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05109.x · Cited by 87

Dihydrofolate Reductase Protein Inhibits Its Own Translation by Binding to Dihydrofolate Reductase mRNA Sequences within the Coding Region

Ercikan-Abali, E. A., Banerjee, D., Waltham, M. C., Skacel, N. E., Scotto, K. W., & Bertino, J. R. (1997) · Biochemistry · doi:10.1021/bi971026e · Cited by 87

Haem and folate transport by proton-coupled folate transporter/haem carrier protein 1 (SLC46A1)

Laftah, A. H., Latunde-Dada, G. O., Fakih, S., Hider, R. C., Simpson, R. J., & McKie, A. T. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508066762 · Cited by 87

Synthesis and Discovery of High Affinity Folate Receptor-Specific Glycinamide Ribonucleotide Formyltransferase Inhibitors with Antitumor Activity

Deng, Y., Wang, Y., Cherian, C., Hou, Z., Buck, S. A., Matherly, L. H., & Gangjee, A. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8003366 · Cited by 81

Increased Level of Dihydrofolic Reductase in Leucocytes of Patients Treated with Amethopterin

Bertino, J. R., DONOHUE, D. R., Gabrio, B. W., Silber, R., Alenty, A., MEYER, M., & Huennekens, F. M. (1962) · Nature · doi:10.1038/193140a0 · Cited by 79

Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells

Chu, E., Voeller, D. M., Jones, K. L., Takechi, T., Maley, G. F., Maley, F., Segal, S., & Allegra, C. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.207 · Cited by 79

A novel loss-of-function mutation in the proton-coupled folate transporter from a patient with hereditary folate malabsorption reveals that Arg 113 is crucial for function

Lasry, I., Berman, B., Straussberg, R., Sofer, Y., Bessler, H., Sharkia, M., Glaser, F., Jansen, G., Drori, S., & Assaraf, Y. G. (2008) · Blood · doi:10.1182/blood-2008-04-150276 · Cited by 78

Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.

Chung, K. N., Saikawa, Y., Paik, T.-H., et al. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116327 · Cited by 78

Identification of methotrexate transport deficiency in mammalian cells using fluoresceinated methotrexate and flow cytometry.

Assaraf, Y. G., & SCHIMKE, R. T. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7154 · Cited by 77

Vitamin D3 and Its Nuclear Receptor Increase the Expression and Activity of the Human Proton-Coupled Folate Transporter

Eloranta, J. J., Zaïr, Z. M., Hiller, C., Häusler, S., Stieger, B., & Kullak-Ublick, G. A. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055392 · Cited by 77

Roles of folylpoly-gamma-glutamate synthetase in therapeutics with tetrahydrofolate antimetabolites: an overview.

Rg, M. (1999) · PubMed · Cited by 77

Structural requirements for anion substrates of the methotrexate transport system in L1210 cells

Henderson, G. B., & Zevely, E. M. (1983) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(83)90162-5 · Cited by 76

Loss of Multidrug Resistance Protein 1 Expression and Folate Efflux Activity Results in a Highly Concentrative Folate Transport in Human Leukemia Cells

Assaraf, Y. G., Rothem, L., Hooijberg, J. H., Stark, M., Ifergan, I., Kathmann, I., Dijkmans, B. A. C., Peters, G. J., & Jansen, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209186200 · Cited by 76

Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors.

Wang, W., Marsh, S., Cassidy, J., & McLeod, H. L. (2001) · PubMed · Cited by 76

Increase of dihydrofolate reductase activity in cultured mammalian cells after exposure to methotrexate.

Hillcoat, B. L., Swett, V., & Bertino, J. R. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.4.1632 · Cited by 75

Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions

Antony, A. C., Tang, Y.-S., Khan, R. A., Biju, M. P., Xiao, X., Li, Q.-J., Sun, X.-L., Jayaram, H. N., & Stabler, S. P. (2004) · Journal of Clinical Investigation · doi:10.1172/jci11548 · Cited by 74

Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells

Morales, C., García, M. J., Ribas, M., Miró, R., Muñoz, M., Caldas, C., & Peinado, M. A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0759 · Cited by 73

Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines

Rothem, L., Ifergan, I., Kaufman, Y., Priest, D. G., Jansen, G., & Assaraf, Y. G. (2002) · Biochemical Journal · doi:10.1042/bj20020801 · Cited by 73

Characterization of a Folate Transporter in HeLa Cells with a Low pH Optimum and High Affinity for Pemetrexed Distinct from the Reduced Folate Carrier

Wang, Y., Zhao, R., & Goldman, I. D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0645 · Cited by 73

Synthesis and Antitumor Activity of a Novel Series of 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Antifolate Inhibitors of Purine Biosynthesis with Selectivity for High Affinity Folate Receptors and the Proton-Coupled Folate Transporter over the Reduced Folate Carrier for Cellular Entry

Wang, L., Cherian, C., Desmoulin, S. K., Polin, L., Deng, Y., Wu, J., Hou, Z., White, K., Kushner, J., Matherly, L. H., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9015729 · Cited by 72

Folate Based Radiopharmaceuticals for Imaging and Therapy of Cancer and Inflammation

Müller, C. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799315777 · Cited by 70

Phase I Study of (6R)-5, 10-Dideazatetrahydrofolate: a Folate Antimetabolite Inhibitory to De Novo Purine Synthesis

Ray, M., Muggia, F. M., Leichman, C. G., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.14.1154 · Cited by 70

Clustering of Mutations in the First Transmembrane Domain of the Human Reduced Folate Carrier in GW1843U89-resistant Leukemia Cells with Impaired Antifolate Transport and Augmented Folate Uptake

Drori, S., Jansen, G., Mauritz, R., Peters, G. J., & Assaraf, Y. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003988200 · Cited by 69

New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.

Schmid, F. A., Sirotnak, F. M., Otter, G. M., & DeGraw, J. I. (1985) · PubMed · Cited by 69

Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA

Lin, X. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.6.1381 · Cited by 68

Approval Summary: Pemetrexed in the Initial Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

Cohen, M. H., Justice, R. L., & Pazdur, R. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0092 · Cited by 68

Thymidylate synthasegene variations: predictive and prognostic markers

Lurje, G., Manegold, P. C., Ning, Y., Pohl, A., Zhang, W., & Lenz, H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0219 · Cited by 67

Enhancement of Folate Receptor α Expression in Tumor Cells Through the Glucocorticoid Receptor: A Promising Means to Improved Tumor Detection and Targeting

Tran, T., Shatnawi, A. A., Zheng, X., Kelley, K. M. M., & Ratnam, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2890 · Cited by 67

pH Dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells

Sierra, E. E., Brigle, K. E., Spinella, M. J., & Goldman, I. D. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00730-7 · Cited by 66

Gamma-glutamyl hydrolase and drug resistance

Schneider, E., & Ryan, T. J. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.05.044 · Cited by 66

Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.

Habeck, L. L., Mendelsohn, L. G., Shih, C., et al. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10251-4 · Cited by 66

Increased Frequency of Expression of Elevated Dihydrofolate Reductase in T-Cell Versus B-Precursor Acute Lymphoblastic Leukemia in Children

Matherly, L. H., Taub, J. W., Wong, S. C., Simpson, P. M., Ekizian, R., Buck, S., Williamson, M. P., Amylon, M. D., Pullen, J., Camitta, B. M., et al. (1997) · Blood · doi:10.1182/blood.v90.2.578 · Cited by 64

On the role of drug penetration in amethopterin resistance of Sarcoma-180 cells in vitro

Hakala, M. T. (1965) · Biochimica et Biophysica Acta (BBA) - Biophysics including Photosynthesis · doi:10.1016/0926-6585(65)90213-x · Cited by 64

Pattern of Mutations that Results in Loss of Reduced Folate Carrier Function under Antifolate Selective Pressure Augmented by Chemical Mutagenesis

Zhao, R., Sharina, I. G., & Goldman, I. D. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26384-7 · Cited by 64

Chapter 4 Molecular Mechanisms of Adaptation to Folate Deficiency

Ifergan, I., & Assaraf, Y. G. (2008) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00404-4 · Cited by 63

Chapter 9 Regulation of Human Dihydrofolate Reductase Activity and Expression

Abali, E. E., Skacel, N. E., Çelikkaya, H., & Hsieh, Y. (2008) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00409-3 · Cited by 63

Phenotypic Expression in Escherichia coli and Nucleotide Sequence of Two Chinese Hamster Lung Cell cDNAs Encoding Different Dihydrofolate Reductases

Melera, P. W., Davide, J. P., Hession, C. A., & Scotto, K. W. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.1.38-48.1984 · Cited by 63

AG2034: a novel inhibitor of glycinamide ribonucleotide formyltransferase

Boritzki, T. J., Barlett, C. A., Zhang, C., Howland, E. F., Margosiak, S. A., Palmer, C. L., Romines, W. H., & Jackson, R. (1996) · Investigational New Drugs · doi:10.1007/bf00194533 · Cited by 63

Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.

Westerhof, G. R., Rijnboutt, S., Schornagel, J. H., Pinedo, H. M., Peters, G. J., & Jansen, G. (1995) · PubMed · Cited by 63

Therapeutic Targeting of a Novel 6-Substituted Pyrrolo [2,3-d]pyrimidine Thienoyl Antifolate to Human Solid Tumors Based on Selective Uptake by the Proton-Coupled Folate Transporter

Desmoulin, S. K., Wang, L., Hales, E. C., Polin, L., White, K., Kushner, J., Stout, M. L., Hou, Z., Cherian, C., Gangjee, A., et al. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073833 · Cited by 62

Structural and Functional Analysis of the Human KB Cell Folate Receptor Gene P4 Promoter: Cooperation of Three Clustered Sp1-Binding Sites with Initiator Region for Basal Promoter Activity

Saikawa, Y., Price, K., Hance, K. W., Chen, T. Y., & Elwood, P. C. (1995) · Biochemistry · doi:10.1021/bi00031a018 · Cited by 61

ABCG2 Harboring the Gly482 Mutation Confers High-Level Resistance to Various Hydrophilic Antifolates

Shafran, A., Ifergan, I., Bram, E. E., Jansen, G., Kathmann, I., Peters, G. J., Robey, R. W., Bates, S. E., & Assaraf, Y. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4547 · Cited by 61

The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis

Hooijberg, J. H., Peters, G. J., Assaraf, Y. G., Kathmann, I., Priest, D. G., Bunni, M. A., Veerman, A. J. P., Scheffer, G. L., Kaspers, G. J. L., & Jansen, G. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01615-5 · Cited by 61

Translational autoregulation of thymidylate synthase and dihydrofolate reductase

Tai, N. (2004) · Frontiers in bioscience · doi:10.2741/1413 · Cited by 60

Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.

Krug, L. M., Ng, K., Kris, M. G., Miller, V. A., Tong, W. P., Heelan, R. T., León, L. F., Leung, D. H. Y., Kelly, J., Grant, S. C., et al. (2000) · PubMed · Cited by 60

Characterization of the gene encoding a folate-binding protein expressed in human placenta. Identification of promoter activity in a G-rich SP1 site linked with the tandemly repeated GGAAG motif for the ets encoded GA-binding protein.

Sadasivan, E., Cedeno, M., & Rothenberg, S. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37605-6 · Cited by 58

The Human Reduced Folate Carrier Gene Is Regulated by the AP2 and Sp1 Transcription Factor Families and a Functional 61-Base Pair Polymorphism

Whetstine, J. R., Witt, T. L., & Matherly, L. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208296200 · Cited by 57

Structure and Regulation of the Murine Reduced Folate Carrier Gene

Liu, M., Ge, Y., Cabelof, D. C., Aboukameel, A., Heydari, A. R., Mohammad, R. M., & Matherly, L. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412662200 · Cited by 57

Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples.

Yang, R. R., Sowers, R. S., Mazza, B., Healey, J. H., Huvos, A. G., Grier, H. E., Bernstein, M. L., Beardsley, G. P., Krailo, M., Devidas, M., et al. (2003) · PubMed · Cited by 57

Selective Preservation of Pemetrexed Pharmacological Activity in HeLa Cells Lacking the Reduced Folate Carrier

Zhao, R., Hanscom, M., Chattopadhyay, S., & Goldman, I. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3953 · Cited by 56

Hypermethylation of the human proton-coupled folate transporter (SLC46A1) minimal trancriptional regulatory region in an antifolate-resistant HeLa cell line

Diop-Bove, N., Wu, J. W., Zhao, R., Locker, J. D., & Goldman, I. D. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0938 · Cited by 56

Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)

Cohen, M. H., Cortazar, P., Justice, R. L., & Pazdur, R. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-0224 · Cited by 56

Loss of Folic Acid Exporter Function with Markedly Augmented Folate Accumulation in Lipophilic Antifolate-resistant Mammalian Cells

Assaraf, Y. G., & Goldman, I. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17460 · Cited by 55

The Mechanism of Action of Methotrexate III. Requirement of Free Intracellular Methotrexate for Maximal Suppression of [14C]Formate Incorporation into Nucleic Acids and Protein

White, J. C., Loftfield, S., & Goldman, I. D. (1975) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10637-8 · Cited by 55

Regulatory aspects of the glutamylation of methotrexate in cultured hepatoma cells

Nimec, Z., & Galivan, J. H. (1983) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(83)90337-5 · Cited by 54

Effects of the loss of capacity for N-glycosylation on the transport activity and cellular localization of the human reduced folate carrier

Wong, S. C., Zhang, L., Proefke, S. A., & Matherly, L. H. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00118-7 · Cited by 54

Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells

Mclvor, R. S., & Simonsen, C. C. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.23.7025 · Cited by 54

Selective delivery of CB300638, a cyclopenta[g]quinazoline-based thymidylate synthase inhibitor into human tumor cell lines overexpressing the alpha-isoform of the folate receptor.

Theti, D. S., Bavetsias, V., Skelton, L., Titley, J. C., Gibbs, D. D., Jansen, G., & Jackman, A. L. (2003) · PubMed · Cited by 53

Identification and characterization of a mutation in the dihydrofolate reductase gene from the methotrexate-resistant Chinese hamster ovary cell line Pro-3 MtxRIII.

Dicker, A. P., Volkenandt, M., Schweitzer, B. I., Banerjee, D., & Bertino, J. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39074-x · Cited by 52

Serine and one-carbon metabolism in cancer

Yang, M., & Vousden, K. H. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.81 · Cited by 992

Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies.

Li, W., Zhang, H., Assaraf, Y. G., Zhao, K., Xu, X., Xie, J., Yang, D.-H., & Chen, Z.-S. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.05.001 · Cited by 673

The multi-factorial nature of clinical multidrug resistance in cancer

Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528

Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance

Erin, N., Grahovac, J., Brozovic, A., & Efferth, T. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100715 · Cited by 527

YAP/TAZ Signaling and Resistance to Cancer Therapy

Nguyen, C. D. K., & Yi, C. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.02.010 · Cited by 437